Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods
Show others and affiliations
Number of Authors: 452020 (English)In: Archives of Toxicology, ISSN 0340-5761, E-ISSN 1432-0738, Vol. 94, no 7, p. 2435-2461Article in journal (Refereed) Published
Abstract [en]

Hazard assessment, based on new approach methods (NAM), requires the use of batteries of assays, where individual tests may be contributed by different laboratories. A unified strategy for such collaborative testing is presented. It details all procedures required to allow test information to be usable for integrated hazard assessment, strategic project decisions and/or for regulatory purposes. The EU-ToxRisk project developed a strategy to provide regulatorily valid data, and exemplified this using a panel of > 20 assays (with > 50 individual endpoints), each exposed to 19 well-known test compounds (e.g. rotenone, colchicine, mercury, paracetamol, rifampicine, paraquat, taxol). Examples of strategy implementation are provided for all aspects required to ensure data validity: (i) documentation of test methods in a publicly accessible database; (ii) deposition of standard operating procedures (SOP) at the European Union DB-ALM repository; (iii) test readiness scoring accoding to defined criteria; (iv) disclosure of the pipeline for data processing; (v) link of uncertainty measures and metadata to the data; (vi) definition of test chemicals, their handling and their behavior in test media; (vii) specification of the test purpose and overall evaluation plans. Moreover, data generation was exemplified by providing results from 25 reporter assays. A complete evaluation of the entire test battery will be described elsewhere. A major learning from the retrospective analysis of this large testing project was the need for thorough definitions of the above strategy aspects, ideally in form of a study pre-registration, to allow adequate interpretation of the data and to ensure overall scientific/toxicological validity.

Place, publisher, year, edition, pages
2020. Vol. 94, no 7, p. 2435-2461
Keywords [en]
GIVIMP, In vitro toxicology, Nuclear receptor, Metadata, Data processing
National Category
Computer and Information Sciences
Identifiers
URN: urn:nbn:se:su:diva-184518DOI: 10.1007/s00204-020-02802-6ISI: 000545934500001PubMedID: 32632539OAI: oai:DiVA.org:su-184518DiVA, id: diva2:1467522
Available from: 2020-09-15 Created: 2020-09-15 Last updated: 2022-02-25Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Brecklinghaus, TimForsby, AnnaJennings, PaulKobolak, JuliannaKumar, ManojLundqvist, JessicaSchimming, Johannes P.Wilmes, Anja

Search in DiVA

By author/editor
Brecklinghaus, TimForsby, AnnaJennings, PaulKobolak, JuliannaKumar, ManojLundqvist, JessicaSchimming, Johannes P.Wilmes, Anja
By organisation
Department of Biochemistry and Biophysics
In the same journal
Archives of Toxicology
Computer and Information Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 73 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf